A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over ...

Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Embecta Corp. (NASDAQ: EMBC) securities between November 25, 2025 and May ...

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Embecta Corp. (“Embecta” or ...

Investors have until August 17, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of ...

On May 5, 2026, Embecta released its second quarter fiscal 2026 financial results, revealing that revenue had declined over 14%, largely due to weakness in its pen needle sales. Additionally, the ...

View Embecta Corporation EMBC stock quote prices, financial information, real-time forecasts, and company news from CNN.

A recent media report suggests Embecta, the company that spun out of BD in April 2022, is exploring a potential sale. Citing two unnamed sources, the Financial Times reported that the company has ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Embecta Corp. (NASDAQ:EMBC) posted on Friday the second-quarter 2025 adjusted earnings of 70 cents per share, up from 67 cents a year ago, beating the consensus of 53 cents. The diabetes care company ...

Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Embecta Corp. (“Embecta” or the “Company”) (NASDAQ: EMBC) investors of the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...